RXi Pharmaceuticals Corporation
60 Prescott Street
Worcester,
MA 01605
Phone: 508-767-3861
Fax: 508-767-3862
Web Site: http://www.rxipharma.com
| REUTERS ABRIDGED BUSINESS SUMMARY | |
| RXi Pharmaceuticals Corporation, a discovery-stage biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on RNA interference for the treatment of human diseases in the United States and internationally. It intends to identify lead compounds and advance towards pre-clinical and clinical development programs in various therapeutic areas, including inflammatory disease; and metabolic diseases, such as obesity and obesity-related type 2 diabetes. The company was formerly known as Argonaut Pharmaceuticals, Inc. and changed its name to RXi Pharmaceuticals Corporation in 2006 before beginning operations in 2007. RXi Pharmaceuticals was founded in 2003 and is based in Worcester, Massachusetts. |
|
| Key Statistics | More from Reuters
Expanded Business Description |
| |
| REUTERS ABRIDGED FINANCIAL SUMMARY | |
| | Pay | Exercised | Dr. Tod Woolf Ph.D., 45
Founder and Member of the Scientific Advisory Board |
$
330.00K | N/A | Mr. Steven A. Kriegsman , 67
Director, Chairman of Strategy Committee, Chief Exec. Officer of CytRx and Pres of CytRx |
$
68.00K | N/A | Dr. Pamela A. Pavco Ph.D., 54
VP of Pharmaceutical Devel. |
$
240.00K | N/A | Mr. Noah D. Beerman , 48
Chief Exec. Officer and Pres |
N/A
| N/A | Dr. Craig C. Mello Ph.D.,
Co-Founder and Chairman of Scientific Advisory Board |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
Reuters offers more in-depth
